Charles Campbell Roberts is chief investment strategist for private equity at ARK Invest and a co-founder and chair of Relation Therapeutics. He also co-founded Freenome, Agalimmune and Centauri Therapeutics, building companies at the intersection of AI and biology.
Charles Campbell Roberts is chief investment strategist for private equity at ARK Invest and a co-founder and chair of Relation Therapeutics. He also co-founded Freenome, Agalimmune and Centauri Therapeutics, building companies at the intersection of AI and biology.
Career
Chief Investment Strategist. Private Equity at ARK Invest until Present
Co-founder and Chair at Relation Therapeutics until Present